Resmed

Resmed's reported carbon emissions

ResMed, a company in the Medical, precision and optical instruments, watches and clocks industry, based in the US, has reported its carbon emissions with a focus on Scopes 1 and 2. In 2024, ResMed reported Scope 1 emissions of approximately 4.24 million kg CO2e and Scope 2 emissions of approximately 24.42 million kg CO2e, bringing their combined Scope 1 and 2 total to approximately 28.66 million kg CO2e. For 2023, the company's Scope 1 emissions were about 4.45 million kg CO2e and Scope 2 emissions were approximately 23.94 million kg CO2e, with a combined total of around 28.39 million kg CO2e. In 2022, ResMed's Scope 1 emissions were approximately 3.74 million kg CO2e and Scope 2 emissions were approximately 21.32 million kg CO2e, resulting in a combined total of about 25.06 million kg CO2e. ResMed has set ambitious climate commitments, including a near-term target to reduce Scope 1 emissions to near zero by the middle of this decade. Additionally, they aim to reduce Scope 2 emissions to near zero by the same timeframe. Further solidifying their climate strategy, ResMed has committed to reduce absolute Scope 1 and 2 greenhouse gas emissions by 42% by FY2030 from a FY2022 base year. They also aim to reduce Scope 3 GHG emissions by 51.6% per MW constructed within the same timeframe. Long-term, ResMed is committed to reaching net-zero greenhouse gas emissions across its value chain by FY2050, with a long-term target to reduce Scope 1 and 2 GHG emissions by 90% by FY2050 from a FY2022 base year, and Scope 3 GHG emissions by 97% per MW constructed.